Dr. Reddy's Laboratories Ltd

Dr. Reddy's Laboratories Ltd is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. Dr. Reddy's Laboratories Ltd is a strong company with an excellent Piotroski F-score. Dr. Reddy's Laboratories Ltd is not very popular among insiders. Dr. Reddy's Laboratories Ltd is a mediocre stock to choose.
Log in to see more information.
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. I...

News

Dr. Reddy's Shareholders Approve Stock Split
Dr. Reddy's Shareholders Approve Stock Split

TipRanks Financial Blog Dr Reddy's Laboratories (RDY) has released an update. Dr. Reddy's Laboratories Ltd. has announced that its shareholders approved the subdivision of its equity share...\n more…

Acadian Asset Management LLC Has $20.50 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)
Acadian Asset Management LLC Has $20.50 Million Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)

Ticker Report Acadian Asset Management LLC lifted its stake in Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 37.2% during the second quarter, according to its most recent disclosure with the...\n more…

Candriam S.C.A. Sells 10,000 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)
Candriam S.C.A. Sells 10,000 Shares of Dr. Reddy's Laboratories Limited (NYSE:RDY)

Ticker Report Candriam S.C.A. lessened its holdings in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) by 20.0% during the 2nd quarter, according to its most recent disclosure with the SEC. The...\n more…

Dr Reddy's gets USFDA's inspection report for Srikakulam-based API plant
Dr Reddy's gets USFDA's inspection report for Srikakulam-based API plant

Business Standard - Companies & Industry Dr Reddy's Laboratories on Friday said it has received the establishment inspection report (EIR) from the US health regulator for its active pharmaceutical ingredient manufacturing facility (CTO-6...\n more…

Dr Reddy's, Lupin recall products in US due to manufacturing issues: USFDA
Dr Reddy's, Lupin recall products in US due to manufacturing issues: USFDA

Business Standard - Companies & Industry Dr Reddy's Laboratories and Lupin are recalling products in the US due to manufacturing issues, as per the US Food and Drug Administration (USFDA).\nDr Reddy's Laboratories Inc, a subsidiary of...\n more…

Drive Wealth Management LLC Takes $206,000 Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)
Drive Wealth Management LLC Takes $206,000 Position in Dr. Reddy's Laboratories Limited (NYSE:RDY)

Ticker Report Drive Wealth Management LLC acquired a new position in shares of Dr. Reddy's Laboratories Limited (NYSE:RDY - Free Report) in the second quarter, HoldingsChannel.com reports. The institutional...\n more…